Brigham Buhler: There's a lot of levers that big pharma can pull

"There's a lot of levers that big pharma can pull. And I've learned the hard way. They have a pretty good stronghold on the FDA and a large portion. Like I said earlier, 50% of the FDA's funding comes from big pharma. I definitely believe that big pharma does not want. Trump and Bobby Kennedy in power because it's not good for that machine."

So I don't know if you're aware, the FDA attempted to say that GLP ones, these, they're technically diabetes medications that are being marketed as weight loss drugs, but GLP ones disproportionately help poverty stricken and minority communities because diabetes disproportionately impacts those communities. And it's not readily available in this country."

"And I actually have a clip that we made about it, but it's not available because Lilly and some of these companies have their own facilities getting shut down and the way they've marketed these products, they're being used for weight loss by everyone and their mom across the country. And it's hard for the people, the diabetics that really need this medicine to get this medicine."

"And so you would think that we would want to make sure that compounding pharmacies and the lifeblood of, you know, our pharmaceutical interventions in this country were protected. In fact, the FDA asked compounding pharmacies to make these compounds. for the American people because the back order. And what happens is as soon as these big pharmaceutical companies begin to pressure the FDA, the FDA oftentimes caves."

"And that happened a few weeks ago. The FDA caved and said, we're gonna immediately remove GLP-1s from the backlog list, but it's still on a backlog across the country. The reason that's important is that means diabetics and poverty stricken communities and people who can't get to these medicines would not have accessibility. In an effort to prevent that several compounding pharmacies sued the FDA and within four days the FDA reneged on its original statement and put it back on the backlogs list, meaning compounding pharmacies could compound and bring it to the American people."

"I want the public to know Big Pharma is slick. A lot of people don't know this. Big Pharma already submitted a new petition within days using their powerhouse attorneys trying to now reclassify GLP-1s as dangerous to compound. And they are leaning heavily on the FDA to shut down the ability of compounding pharmacies to make this life, not just life changing, life saving compound inaccessible to the American people. And they did this in the 80s. So again, if we look at it, where's it headed? I go back to where has it been?"